Moore Kuehn Encourages FRGI, VRTV, SCU, and PRDS Investors
NEW YORK, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York...
Source: globenewswire.com
Pardes Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pardes Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pardes Bioscience Today - Breaking & Trending Today
Moore Kuehn Encourages PRDS, AMNB, NLTX, and SCU Investors to Contact Law Firm
/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...
Source: prnewswire.com
Pardes Biosciences Reports First Quarter 2023 Financial
CARLSBAD, Calif., May 05, 2023 (GLOBE NEWSWIRE) -- Pardes Biosciences, Inc. (NASDAQ: PRDS) today reported financial results for the first quarter ended...
Source: globenewswire.com
Pardes Biosciences (NASDAQ:PRDS) Downgraded to "Hold" at Jefferies Financial Group
Jefferies Financial Group lowered shares of Pardes Biosciences (NASDAQ:PRDS – Get Rating) from a buy rating to a hold rating in a research note issued to investors on Monday, The Fly reports. Jefferies Financial Group also issued estimates for Pardes Biosciences’ Q2 2023 earnings at ($0.36) EPS, Q3 2023 earnings at ($0.27) EPS, Q4 2023 […]
Source: kopsource.com
Jefferies Financial Group Analysts Reduce Earnings Estimates for Pardes Biosciences, Inc. (NASDAQ:PRDS)
Pardes Biosciences, Inc. (NASDAQ:PRDS – Get Rating) – Research analysts at Jefferies Financial Group decreased their Q2 2023 EPS estimates for Pardes Biosciences in a research report issued on Monday, April 3rd. Jefferies Financial Group analyst D. Ding now expects that the company will earn ($0.36) per share for the quarter, down from their previous […]
Source: modernreaders.com